(R)-6-((4,6-dihydropyrazolo[1,5-c]thiazol-2-yl)methylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate

ID: ALA1673091

Chembl Id: CHEMBL1673091

PubChem CID: 53319078

Max Phase: Preclinical

Molecular Formula: C12H9N3O3S2

Molecular Weight: 307.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)C1=CS[C@@H]2/C(=C\c3cc4n(n3)CSC4)C(=O)N12

Standard InChI:  InChI=1S/C12H9N3O3S2/c16-10-8(11-15(10)9(4-20-11)12(17)18)2-6-1-7-3-19-5-14(7)13-6/h1-2,4,11H,3,5H2,(H,17,18)/b8-2-/t11-/m1/s1

Standard InChI Key:  PIQJFYXOGLAPEL-GPWUBDCCSA-N

Alternative Forms

  1. Parent:

    ALA1673091

    PENEM-1

Associated Targets(non-human)

bla Beta-lactamase SHV-5 (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaSHV-95 Beta-lactamase SHV-95 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Beta-lactamase SHV-1 (117 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaSHV-48 Extended-spectrum beta-lactamase SHV-48 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 307.36Molecular Weight (Monoisotopic): 307.0085AlogP: 1.31#Rotatable Bonds: 2
Polar Surface Area: 75.43Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.44CX Basic pKa: 2.12CX LogP: -0.03CX LogD: -3.22
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.66Np Likeness Score: -0.60

References

1. Bethel CR, Distler AM, Ruszczycky MW, Carey MP, Carey PR, Hujer AM, Taracila M, Helfand MS, Thomson JM, Kalp M, Anderson VE, Leonard DA, Hujer KM, Abe T, Venkatesan AM, Mansour TS, Bonomo RA..  (2008)  Inhibition of OXA-1 beta-lactamase by penems.,  52  (9): [PMID:18559643] [10.1128/aac.01677-07]
2. Baig MH, Shakil S, Khan AU.  (2012)  Homology modeling and docking study of recent SHV type -lactamses with traditional and novel inhibitors: an in silico approach to combat problem of multiple drug resistance in various infections,  21  (9): [10.1007/s00044-011-9736-8]

Source